Healthy Skepticism Library item: 4003

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Re: the promotion of nicergoline
1989 May;

Abstract:

Farmitalia Carlo Erba responded to an earlier MaLAM letter about the use of nicergoline in senile dementia, stroke and Parkinson’s disease but MaLAM still has concerns about the drug’s effectiveness.

Keywords:
*analysis/Farmitalia Carlo Erba/nicergoline/ neurologic drugs/MaLAM/Medical Lobby for Appropriate Marketing/ quality of information/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: NEUROLOGIC DISEASES